<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05018988</url>
  </required_header>
  <id_info>
    <org_study_id>DVinCHI_UU2019</org_study_id>
    <nct_id>NCT05018988</nct_id>
  </id_info>
  <brief_title>Vitamin D in School Children</brief_title>
  <acronym>DVinCHI</acronym>
  <official_title>The D-VinCHI Study: 25-hydroxyvitamin D Concentration in School Children: Effects of Vitamin D3 Supplementation on 25-OH-D Concentration and Muscle Health Outcomes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Ulster</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Queen Margaret University, Nutrition and Biological Sciences, Musselburgh, Scotland, UK</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Better You ltd., Unit 24 Shortwood Court, Shortwood Business Park, Dearne Valley Parkway, Barnsley, S74 9LH, Registered Company No: 05541287</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Ulster</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary purpose of this study it to investigate total circulating 25-hydroxyvitamin D&#xD;
      (25(OH)D) in school children (aged 4-11years) in Northern Ireland; thereby establishing the&#xD;
      prevalence of vitamin D status (deficiency, insufficiency, and sufficiency (SACN 2016)) in&#xD;
      this cohort. Additionally, the study aims to determine if 10µg/day vitamin D3 supplementation&#xD;
      over 12 weeks maintains vitamin D status.&#xD;
&#xD;
      This area of research is lacking in the quality of prospective studies. While previous&#xD;
      literature has focused on the prevalence of vitamin D status in adults, there is a paucity of&#xD;
      data available for children. This study will add to the existing knowledge and provide more&#xD;
      specific analysis for children.&#xD;
&#xD;
      Hypothesis 1: Increase in vitamin D concentrations will be associated with an improvement in&#xD;
      health outcomes including anthropometric measurements, musculoskeletal outcomes, markers of&#xD;
      inflammation, nutritional status and bone turnover, lipid profiles, cognitive function, and&#xD;
      handgrip strength.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The main objectives of this study are to determine prevalence of vitamin D status in&#xD;
      4-11-year-old children and to investigate if 10µg/day maintains vitamin D status in this&#xD;
      population. This study will focus on children aged 4-11 years old residing in Northern&#xD;
      Ireland. This 2-phase study will incorporate an observational phase and intervention phase to&#xD;
      determine prevalence and status, respectively. The expected time under study will be 12 weeks&#xD;
      and the number of visits will be limited to two per participant. Where participants are from&#xD;
      the same home, randomisation to the same treatment group will occur. Results will be&#xD;
      controlled for season.&#xD;
&#xD;
      Vitamin D deficiency is prevalent across the global population including those who reside&#xD;
      above 37° North. In addition to a lack of rich dietary sources of vitamin D, residing at this&#xD;
      latitude restricts exposure to sunlight due to the zenith angle of the sun. Although vitamin&#xD;
      D deficiency is rife in the general population there are certain categories who are at&#xD;
      additional risk of vitamin D deficiency including pregnant women, elderly, and&#xD;
      institutionalized populations. One population group where there is still a paucity of&#xD;
      studies, and a lack of clear guidelines are children. Recent evidence suggests that vitamin D&#xD;
      has potential to provide extra skeletal health benefits.&#xD;
&#xD;
      Assessments to be undertaken in this study include anthropometric, handgrip, balance,&#xD;
      cognitive function. These assessments will be followed by a 20ml blood draw completed by a&#xD;
      trained researcher who is trained in phlebotomy. Additionally, parents will be asked to&#xD;
      complete a validated vitamin D food frequency questionnaire and four-day weighed diet diary&#xD;
      for their offspring. This study will determine if the recommended supplementation regimen&#xD;
      results in the intervention population reporting a sufficient vitamin D status. Blood samples&#xD;
      will be analysed for 25(OH)D, serum parathyroid hormone (PTH), serum C-reactive protein&#xD;
      (CRP), serum HbA1c (glycated haemoglobin), markers of bone turnover, markers of inflammation,&#xD;
      full blood count, lipid profile, and markers of nutritional status. Circulating 25(OH)D will&#xD;
      be assessed via liquid chromatography- mass spectrometry (HPLC &amp; MS).&#xD;
&#xD;
      Sample size was calculated using G*Power software available at QMU (G*Power) by entering the&#xD;
      planned statistical analysis method (i.e. t-test or ANOVA), desired effect size (0.5), and&#xD;
      experimental design (i.e. two groups with two outcomes). Phase one (observational study) with&#xD;
      an effect size of 0.15 requires a total population of 200. Phase two (intervention study)&#xD;
      with an effect size of 0.15 requires a total population of 118 (59 in each arm) including a&#xD;
      dropout rate of 20%. A total population of 55 is required for Food frequency validation&#xD;
      including a 10% dropout rate and for the vitamin D knowledge questionnaire with an effect&#xD;
      size of 0.8 a total population of 70 is required.&#xD;
&#xD;
      The planned statistical analysis will be conducted in IBM SPSS and with intention to treat.&#xD;
      Results from phase one will be analysed using descriptive statistics. A regression model will&#xD;
      be used to determine prediction models for circulating 25(OH)D and the reported secondary&#xD;
      outcomes.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 1, 2019</start_date>
  <completion_date type="Anticipated">October 30, 2025</completion_date>
  <primary_completion_date type="Anticipated">October 30, 2025</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Observational study followed double blinded randomised control trial</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
    <masking_description>Double blinded to participant and researcher</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Plasma 25-hydroxy vitamin D concentration</measure>
    <time_frame>Change over 12 weeks</time_frame>
    <description>Measured by LC/MS</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Muscle strength</measure>
    <time_frame>Change over 12 weeks</time_frame>
    <description>Hand grip strength by a dynamometer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postural balance</measure>
    <time_frame>Change over 12 weeks</time_frame>
    <description>Assessed using single leg stance (SLS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postural balance</measure>
    <time_frame>Change over 12 weeks</time_frame>
    <description>Assessed using tandem stance (TS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cognitive function</measure>
    <time_frame>Change over 12 weeks</time_frame>
    <description>Assessed using three CANTAB batteries</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">118</enrollment>
  <condition>Vitamin D Deficiency</condition>
  <condition>Musculoskeletal Diseases</condition>
  <condition>Cognitive Delay, Mild</condition>
  <arm_group>
    <arm_group_label>Oral vitamin D3 spray</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>10µg/day for 12 weeks (BetterYou ltd.)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo Comparator</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Xylitol (BetterYou ltd.)</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Oral vitamin D spray</intervention_name>
    <description>1 spray (10µg) /day for 12 weeks</description>
    <arm_group_label>Oral vitamin D3 spray</arm_group_label>
    <other_name>vitamin D3</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>1 spray / day for 12 weeks</description>
    <arm_group_label>Placebo Comparator</arm_group_label>
    <other_name>Xylitol</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Healthy children aged 4-11 years attending school in Northern Ireland.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Any children on long-term prescription medication; and/or diagnosed with a long-term&#xD;
             or exacerbated health condition or disease (does not exclude children with minor or&#xD;
             mild health conditions).&#xD;
&#xD;
          -  Those previously taking a vitamin D supplement and those not willing to abstain from&#xD;
             starting vitamin D supplements.&#xD;
&#xD;
          -  Those using home sun beds.&#xD;
&#xD;
          -  Those who are planning a family holiday to a sunny country (latitudes below 37°N)&#xD;
             during the duration of the intervention.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>4 Years</minimum_age>
    <maximum_age>11 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Pamela J Magee</last_name>
    <phone>+44 28 7012 4360</phone>
    <email>pj.magee@ulster.ac.uk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Emeir McSorley</last_name>
    <phone>+4402870123543</phone>
    <email>em.mcsorley@ulster.ac.uk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Human Intervention Studies Unit, Ulster University</name>
      <address>
        <city>Coleraine</city>
        <state>Londonderry</state>
        <zip>BT52 1SA</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ruth Price</last_name>
      <phone>+442870123878</phone>
      <email>rk.price@ulster.ac.uk</email>
    </contact>
    <contact_backup>
      <last_name>Julie Sittlington</last_name>
      <phone>+442870124101</phone>
      <email>jj.sittlington@ulster.ac.uk</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>August 17, 2021</study_first_submitted>
  <study_first_submitted_qc>August 23, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 24, 2021</study_first_posted>
  <last_update_submitted>August 23, 2021</last_update_submitted>
  <last_update_submitted_qc>August 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Vitamin D</keyword>
  <keyword>Deficiency</keyword>
  <keyword>vitamin D3</keyword>
  <keyword>supplementation</keyword>
  <keyword>Cholecalciferol</keyword>
  <keyword>school children</keyword>
  <keyword>paediatric</keyword>
  <keyword>25(OH)D</keyword>
  <keyword>hypovitaminosis D</keyword>
  <keyword>postural balance</keyword>
  <keyword>cognitive function</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Musculoskeletal Diseases</mesh_term>
    <mesh_term>Vitamin D Deficiency</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
    <mesh_term>Vitamins</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

